CAI
Caris Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$32.47
−1.17%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$33.51
From 52W high−10.17%
Volume1.78M
Market cap$9.17B
P/E (TTM)87.3x
P/S (TTM)9.3x
Div yield—
Key dataNov 4, 2026
Open
$33.51
From 52W high
−10.17%
Volume
1.78M
Market cap
$9.17B
ValuationView details →
P/E (Fwd)
105.4x
EV/EBITDA
51.2x
P/E (TTM)
87.3x
RSI (14)
52.5
MomentumView details →
1D Return
−1.17%
YTD Return
+18.87%
Similar companies
Latest newsMore news →
Caris Life Sciences, Inc. announced the launch of a national commercial promoting its Caris Detect multi-cancer early detection test, featuring Jordan Spieth.16d agoCaris Life Sciences, Inc. announced that it will report its third-quarter 2026 financial results on November 4, 2026, and host a live webcast at 3:30 p.m.20d ago